- Product Partners
- Supplements Facts
- Scientific References
- Client Reviews
A Treasure Chest of Cardiovascular Benefits…
One of the most important plants in traditional Ayuvedic medicine is Amla - also known as Indian Gooseberry. For thousands of years it’s been used to help with many health concerns.
The health properties of this unique berry have been validated by modern science - thanks to the makers of Capros®, a patented amla extract. Over the last seven years, millions of dollars have been invested in numerous clinical trials involving human participants showing the remarkable benefits of Capros® on cardiovascular and heart health.
The fresh fruit used to make Capros® is organically grown - no pesticides are used. The extract is made without any harmful solvents. The patented process yields an amla extract high in the polyphenol compounds believed to be most responsible for the health properties of Capros® - Emblicanin A and Emblicanin B.
Capros® has been the subject of 8 clinical studies demonstrating heart and cardiovascular benefits in human beings.
One of the key findings is Capros® helps maintain healthy cholesterol levels. In fact, even though study participants already had cholesterol scores considered normal, by taking Capros®, they were able to improve further.
What’s more, Capros® has been shown to help each part of the cholesterol score: LDL cholesterol, HDL cholesterol and triglyceride levels.
Capros® also helps boost nitric oxide levels. Nitric oxide helps blood vessels relax, resulting in better blood flow. Capros® also aids in blood flowing smoother by promoting normal platelet function.
Why Capros® Is the Superior Amla. As Shown in 8 Human Clinical Studies
Amla is considered one of the most important medicinal berries in the Indian traditional system of medicine. Harvested from branches up to 40 feet above ground, Amla contains unique polyphenols that offer a multitude of health benefits.
The most notable of these polyphenols are Emblicanin A and Emblicanin B. Emblicanins are different from most other polyphenol antioxidants because they 1) have a cascading antioxidant effect and 2) resist becoming unwanted pro-oxidants.
By cascading effect, it means the antioxidant is not “one and done” when it comes to neutralizing free radicals. Instead, it recycles itself to provide longer lasting protection against oxidative stress.
Even better, while some antioxidants exhibit pro-oxidant activity after they’ve neutralized a free radical, this is not an issue with Amla. Emblicanins do not have any pro-oxidant effects.
Despite its rich history in traditional medicine and strong nutritional profile, until recently very little scientific clinical studies had been conducted on Amla.
That changed five years ago when the makes of Capros® committed to spend millions of dollars on human clinical studies on their patented Capros® amla ingredient.
Natreon, Inc., the maker of Capros®, was willing to make this investment because they knew they had the premier Amla ingredient.
In fact, Capros®, delivers up to 2 times more of the key amla polyphenols than regular amla extracts.
To achieve this, fresh amla berries are picked at their peak potency to maximize polyphenol levels. Organic methods are used on the amla farm - no pesticides or harmful chemicals are ever employed.
Immediately after pressing juice from the berries - the juice is stabilized so no key compounds are lost. No harmful solvents are used in the extraction process.
In addition to testing for potency, two independent labs test for microbials and heavy metals - ensuring that the Capros® powder is both potent and meets purity standards.
To date, Capros® has been the subject of eight human clinical studies - each showing remarkable potential for improving heart and cardiovascular health and reducing oxidative stress.
Dietary Supplement / 30 Veggie Capsules
Serving Size: 1 Capsule
Servings per Container: 30
|Amount Per Serving|
|Capros® Amla Fruit Extract(Phyllanthus emblica) (standardized tominimum 60% tannins)||500 mg*|
* Daily value not established.
Other ingredients: hypromellose, microcrystalline cellulose, croscarmellose sodium, vegetable stearic acid, silica.
Capros® is a registered trademark of Natreon, Inc.
Suggested Use: Take one (1) capsule daily. For increased benefits, take one (1) capsule twice (2) a day, at separate times of day.
TrueCapros™ is a patented extract of amla fruit that helps promote cardiovascular health.†
Keep out of reach of children.
Store at 15-30° C (59-86° F).
Protect from heat, light and moisture.
Do not purchase if seal is broken.
†These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
- Gluten Free
- Assembled in the USA
Manufactured for and Distributed by: NatureCity®
Boca Raton, FL 33487 www.naturecity.com
To re-order call toll free 1-800-593-2563
Khanna S, Das A, Spieldenner J, Rink C, Roy S. “Supplementation of a Standardized Extract from Phyllanthus emblica Improves Cardiovascular Risk Factors and Platelet Aggregation in Overweight/Class-1 Obese Adults.” Journal of Medicinal Food. 2015 18 (4) 415-420.
Fatima N, Pingali U, Muralidhar N. “Study of pharmacodynamic interaction of Phyllanthus emblica extract with clopidogrel and ecosprin in patients with type II diabetes mellitus.” Phytomedicine. 2014 Apr 15;21(5):579-85.
Fatima N, Pingali U, Pilli R. "Capros may mitigate cold pressor stress induced cardiovascular changes." Pharmacognosy Research, January-March 2014, Volume 6, Issue 1, pp 29-35.
Pingali U, Fatima N, Muralidhar N. “Effects of Phyllanthus emblica extract on endothelial dysfunction and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: a randomized, double-blind, controlled study.” Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. July 2013 Volume 2013:6 Pages 275-284.
Usharani P, Fatima N, Muralidhar N: “Effects of Phyllanthus emblica extract on endothelial dysfunction and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: A randomized, double-blind, controlled study.” Diabetes Metab Syndr Obes 2013;6:275–284.
Usharani P, Kishan PV, Fatima N, Kumar UC: “A comparative study to evaluate the effect of highly standardised aqueous extracts of Phyllanthus emblica, withania somnifera and their combination on endothelial dysfunction and biomarkers in patients with type II diabetes mellitus.” Int J Pharm Sci Res 2014;5: 2687–2697.
Usharani P, Sravanti IV. “Evaluation of effect of Emblica officinalis (Capros) on mental stress induced cardiovascular changes in healthy human subjects” Awaiting publication
Usharani P, et. al.: “Study of Capros and Placebo on Endothelial dysfunction in Metabolic syndrome” Department of Clinical Pharmacology and Therapeutics Nizam’s Institute of Medical Sciences Punjagutta, Hyderabad, Andhra Pradesh, India. Awaiting publication
Biswas TK, Cakrabarti S, Pandit S, Jana U, Dey SK. “Clinical evaluation of a Standardized extract of Emblica officinalis fruits for improvement of cardio-respiratory and antioxidant status of volunteers with long smoking history” Awaiting publication
Other Amla Studies
Akhtar MS, Ramzan A, Ali A, Ahmad M. “Effect of Amla fruit (Emblica officinalis Gaertn.) on blood glucose and lipid profile of normal subjects and type 2 diabetic patients.” International Journal of Food Sciences and Nutrition. 2011 Sep;62(6):60.
Muhammad, S.A., Ayesha, R., Amanat, A., Ahmad, M., Effect of amla fruit (Emblica officinalis Gaertn.) on blood glucose and lipid profile of normal subjects and type 2 diabetic patients. International Journal of Food Sciences and Nutrition. 2011. 62, 606–616.
Chen TS, Liou SY, Chang YL. “Supplementation of Emblica officinalis (Amla) extract reduces oxidative stress in uremic patients.” The American Journal of Chinese Medicine. 2009;37(1):19-25.
Jacob A, Pandey M, Kapoor S, Saroja R. “Effect of the Indian gooseberry (amla) on serum cholesterol levels in men aged 35-55 years.” European Journal of Clinical Nutitionr. 1988;42(11):939-944.